Objective-To determine the role of patched receptor (Ptc)-1 in mediating pulsatile flow-induced changes in vascular smooth muscle cell growth and vascular remodeling. Approach and Results-In vitro, human coronary arterial smooth muscle cells were exposed to normal or pathological low pulsatile flow conditions for 24 hours using a perfused transcapillary flow system. Low pulsatile flow increased vascular smooth muscle cell proliferation when compared with normal flow conditions. Inhibition of Ptc-1 by cyclopamine attenuated low flow-induced increases in Notch expression while concomitantly decreasing human coronary arterial smooth muscle cell growth to that similar under normal flow conditions. In vivo, ligation injury-induced low flow increased vascular smooth muscle cell growth and vascular remodeling, while increasing Ptc-1/Notch expression. Perivascular delivery of Ptc-1 small interfering RNA by pluronic gel inhibited the pathological low flow-induced increases in Ptc-1/ Notch expression and markedly reduced the subsequent vascular remodeling. 
V ascular remodeling occurs as a result of alterations in vascular smooth muscle cell (VSMC) proliferation and apoptosis, and is a key event in the pathogenesis of vascular disease. Atherosclerosis, arteriosclerosis, vascular rejection, venous graft restenosis, and coronary intervention are each characterized by increased VSMC growth and remodeling [1] [2] [3] [4] that occurs at vessel branch points and bifurcations where blood flow is perturbed. This pathological low flow or proatherogenic flow type occurs at the curves and bifurcations of large artery and arteriole branch points, which are the regions that remodel over time. Understanding how VSMC transduce pulsatile flow stimuli into intracellular biomechanical signals that promote VSMC growth and subsequent remodeling is unclear at present. We have previously shown that the biomechanical stimulation (shear stress and cyclic strain) of adult VSMC that contribute to the growth response of these cells involves Hedgehog and Notch signaling components. [5] [6] [7] Moreover, we have recently shown that vascular injury-induced remodeling involves a marked upregulation of both Notch and Hedgehog signaling. 5 However, how these signaling pathways coordinate in an altered hemodynamic environment to promote vascular remodeling in the pathogenesis of vascular disease remains unexplored.
Hedgehogs (Hh) are a class of 19-kDa morphogens that interact with heparin on the cell surface through an N-terminal basic domain and are tethered to the surface through cholesterol and fatty acyl modification. 8 Sonic Hh is the most widely expressed hedgehog during development where lack of Sonic Hh is embryonically lethal. 8 Signaling occurs through interaction with the Patched receptors (Ptc-1 and 2) that then activate the transcription factors Gli1, Gli2, and Gli3. The downstream targets of the Gli gene products include both Ptc and Gli themselves; thus, Ptc and Gli are both components and targets of the Hh signaling pathway. Hedgehog signaling, which has been well characterized as having an involvement in the development of embryonic lineages, has also been shown to promote VSMC growth and survival in adult tissue. [9] [10] [11] In addition, Notch signaling has also been implicated as a critical determinant of VSMC survival and vascular structure through modulation of signaling pathways that regulate growth. [12] [13] [14] [15] We and others have recently demonstrated that Hh can regulate the expression of Notch target genes in a variety of cell types, supporting an interaction between these 2 pathways. 5, 7, 11, 16, 17 Given these reports in the literature and our previous studies supporting biomechanical regulation of both Hh and Notch signaling components in VSMC in vitro and in the injury-induced remodeled vessel in vivo, we examined whether Ptc-1 mediates pathological low flow-induced neointimal hyperplasia via regulation of the Notch signaling pathway.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Ptc-1 Mediates Pulsatile Flow-Induced Changes in HCASMC Growth In Vitro via a Notch-Dependent Pathway
The effect of Ptc-1 inhibition on low pulsatile flow-induced Notch and human coronary arterial smooth muscle cell (HCASMC) growth was determined using cells grown in a perfused transcapillary culture system under different flow conditions. Low flow enhanced proliferating cell nuclear antigen (PCNA) expression and increased HCASMC cell number over time when compared with normal flow ( Figure 1A ). Ptc-1 inhibition with cyclopamine (40 μmol/L) treatment for 24 hours resulted in a complete attenuation of low flow-induced increases in HCASMC growth as determined by PCNA expression (24 hours) and cell counts during 5 days ( Figure 1A) . In parallel studies, inhibition of Ptc-1 signaling for 24 hours resulted in a decrease in low flow-induced Ptc-1 and Gli2 mRNA expression by 80.0%±6 and 72.0%±4, respectively ( Figure 1B 
Pathological Low Flow Promotes Neointimal Hyperplasia via a Ptc-1/Notch-Dependent Pathway
Partial ligation of the carotid artery in a wild-type C57BL/6J mouse led to a 90% reduction in pulsatile flow when compared with sham-operated controls as previously shown. 5, 18 This induced a reproducible remodeling response, assessed 2 weeks after ligation that included an increase in SMC growth as compared with sham-operated vessels ( Figure 2A ). Vascular remodeling was inhibited after perivascular delivery of Ptc-1 siRNA in mice when compared with perivascular delivery of control-scrambled siRNA ( Figure 2B ). The pathological low flow-induced increase in SMC medial and neointimal volume was reduced to sham-operated levels after localized Ptc-1 gene knockdown ( Figure 2B ), whereas the low flowinduced decreases in lumen volume were abrogated to shamoperated control levels after Ptc-1 knockdown ( Figure 2B ). Low-flow-induced intimal medial thickness volume was significantly reduced after perivascular delivery of Ptc-1 siRNA ( Figure 2C ).
Notch component and Ptc-1 mRNA levels were determined in the carotid arteries of ligated animals and compared with sham. There was a significant increase in Notch1 and Hrt-2 mRNA levels in ligated vessels ( Figure II in the online-only Data Supplement). In addition, Ptc-1, Gli2, Notch 1, and Hrt-2 mRNA levels were determined in the carotid arteries of sham, control-scrambled siRNA ligated and Ptc-1 siRNA ligated vessels. The injury-induced low flow increases in Ptc-1, Gli2, Notch 1, and Hrt-2 mRNA levels were reversed after selective knockdown of Ptc-1 by siRNA ( Figure 3A) . Similarly, injury-induced increases in Ptc-1, Notch 1IC, and PCNA protein were significantly attenuated after Ptc-1 gene knockdown ( Figure 3B ). Parallel studies confirmed Ptc1-mediated inhibition of Notch1 stimulated HCASMC PCNA expression in vitro ( Figure III in the online-only Data Supplement).
Immunohistochemical examination of fixed tissue sections of carotids from sham-operated control vessels, scrambled siRNA ligated vessels, and Ptc-1 siRNA ligated vessels revealed Ptc-1 expression in both the adventitia and SMCrich media by costaining with SMC α-actin ( Figure 3C ). Decreased SMC Ptc-1 concomitant with a reduction in intima medial thickening and a decrease in SMC growth after Ptc-1 gene knockdown was evident by dual immunofluorescence staining with α-actin ( Figure 3C ).
Discussion
During the past decade, we and others have investigated a role for the Notch and Hh signaling pathways in adult vascular cells and, in particular, how these pathways arbitrate cell fate decisions in normal and disease states.
5,7,18-20 A fundamental role for these pathways in vascular development is well established, but their recapitulation in adult cells and subsequent pathological role warrants further exploration. To date we have determined that both Notch and Hh signaling pathways can mediate adult SMC growth, and that these pathways are sensitive to biomechanical regulation in this cell type and in endothelial cells. 7, 21, 22 Moreover, the biomechanically mediated changes in SMC growth are at least, in part, a Hh and Notch-dependent event. The novelty of our current study is that for the first time we show that the pathological flowinduced changes in SMC growth seen both in culture and in the injury-induced vessel occur via Ptc-1 regulation of downstream Notch signaling.
We established in vitro that pathological low flow induces a significant increase in proproliferative Hh signaling via ptc-1 regulation of the Notch pathway. Ptc-1 inhibition with cyclopamine resulted in decreased Notch signaling concomitant with a decrease in the low flow-induced SMC growth. Moreover, the importance of these findings was confirmed in vivo using a model of arterial injury where Hh/Notch signaling was significantly increased in the ligated low flow artery in comparison with the normal flow controls. To confirm that these pathological flow-induced changes in Hh/Notch signaling were predominantly SMC specific, antibodies specific for Hh/Notch signaling components were used in tandem with α-actin staining antibodies. In addition, Laser Capture Microdissection was used to remove the SMC-rich medial layer, which was then analyzed for Hh/Notch RNA expression (data not shown). Both techniques in parallel with whole vessel analysis confirmed that low flow results in increased Hh/Notch signaling, which results in a proproliferative phenotype in these injured vessels promoting vascular remodeling.
We and others have previously established a functional relationship between Hh and Notch signaling and SMC growth in vitro and in vivo. 5, 16, 17 Our previous studies had shown that normal vessels express Ptc-1 primarily in adventitial cells but after vascular injury, medial and intimal SMCs express Ptc-1 in abundance in vivo. 5 In this context, injury-induced Hh stimulation leads to Notch 1IC activation, which in turn results in robust stimulation of downstream Notch target gene expression within these lesions. It is these hrts, which feed into the proliferative (eg, c-myc) and antiapoptotic machinery of the cell by regulating both proapoptotic Bax and antiapoptotic Bcl-X L . However, to our knowledge, this is the first study that directly links Ptc-1 and Notch signaling together in controlling changes in SMC phenotype resulting from altered pulsatile flow.
In this study, we used a perivascular delivery system of gene-specific siRNAs by using a pluronic gel for localized delivery. [23] [24] [25] After pluronic gel delivery of Ptc-1 siRNA, which targets the desired siRNA to an area below the bifurcation of the ligated carotid artery, we achieved a significant inhibition of Ptc-1 mRNA and protein expression. Furthermore, this localized delivery of ptc-1 siRNA resulted in a marked inhibition of Notch signaling concomitant with decreased SMC medial growth and reduced low flow-induced remodeling. This study compliments recent work by Li et al 26 that addressed the role of Notch 1 in neointimal formation after vascular injury. This study indicated a role for Notch 1, rather than Notch 3, in mediating SMC growth and neointimal formation after vascular injury through CHF1/Hey2 using heterozygous Notch1 mutants. 26 In agreement, we demonstrate that Notch1, rather than Notch3, mRNA levels are elevated after injury, an effect that is abrogated after Ptc-1 knockdown. Although the level of neointimal hyperplasia was modest in our model, low flow was associated with significant vascular remodeling, albeit predominantly medial thickening. Vascular remodeling is a major manifestation of arteriosclerosis of the carotid artery, and it is an important predictor of cardiovascular events. The level of carotid remodeling has also a strong genetic component that underlies differences in neointimal hyperplasia among strains. 27 We have previously shown that the effect of vascular endothelial growth factor-A knockdown on sonic Hh-induced hrt-3 expression could be reversed after recovery with exogenous addition of recombinant vascular endothelial growth factor-A. 5 Taken together with our previous work, it is clear that the Hh pathway, including Ptc-1, is an important regulatory molecule upstream of both vascular endothelial growth factor-A and Notch in adult SMCs that govern SMC growth and survival. 28, 29 However, how Ptc-1 is specifically modified by biomechanical forces, which elicit this signaling cascade, warrants further investigation. In addition, it is possible that localized treatment of stenosed vessels with ptc-1-specific siRNA could represent a novel therapy for either restenosis after vein grafting, after angioplasty or atherosclerosis.
In conclusion, we have shown for the first time that pulsatile flow mediates changes in SMC growth via regulation of Ptc-1 signaling, and that local inhibition of Ptc-1 by siRNA prevents low flow-induced vascular remodeling. From this data and our previous studies, it is tempting to speculate that a Hh/Notch axis may represent a novel therapeutic target for disease states where aberrant changes in SMC growth are key to disease pathogenesis. A greater understanding of this signaling cascade within vascular lesions warrants further investigation.
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